Atlas Trials

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Clinical trial NCT01773889 · TERMINATED

Trial details

NCT number
NCT01773889
Sponsor
The University of Texas Health Science Center at San Antonio
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
Start date
2009-06-01
Primary completion
2011-06-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.